ClinicalTrials.Veeva

Menu

Optimal Predilatation Technique for BVS Implantation (OPTI-BVS)

C

Cardiology Center Agel

Status and phase

Unknown
Phase 3

Conditions

Coronary Artery Stenosis

Treatments

Device: Predilatation with cutting balloon (Flextome)
Device: Predilatation with scoring balloon (Scoroflex)
Device: Predilatation with non-compliant balloon

Study type

Interventional

Funder types

Other

Identifiers

NCT02946320
RG4201601

Details and patient eligibility

About

The purpose of this study is to determine the optimal way of predilatation for BVS implantation.

Full description

Randomized, single-center study. Forty-five patients with intended BVS implantation will be randomized in ratio of 1:1:1 to different predilatation strategies(non-compliant balloon/Emerge NC™, Boston Scientific, cutting balloon/Flexitome™, scoring balloon/Scoroflex™,Orbus). Predilatation is intended to be done in a vessel:balloon ratio of 1:1. If the device is not able enter the lesion, it will be replaced with a conventional semicompliant balloon with the same predilatation strategy (a vessel:balloon ratio of 1:1) After a successful predilatation, the BVS (Absorb™, Abbott) will be implanted and this procedure will be accomplished by a high pressure postdilatation with a non-compliant balloon (Emerge NC™, BSCI). The MLA of the Absorb stent will be evaluated with optical coherence tomography (OPTIS, St.Jude).

Enrollment

45 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing percutaneous coronary intervention (PCI)
  • lesion no more than 25 mm in length with a reference-vessel diameter of 2.5 to 3.75 mm on visual assessment

Exclusion criteria

  • patients with acurate myocardial infarction (STEMI)
  • patients with specific complex lesion features (left main, aorto ostial, bifurcation with side branch ≥ 2 mm in diameter, extreme angulation proximal or within the target lesion, moderate or heavy calcification proximal or within the target lesion, chronic total occlusion)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 3 patient groups

Non-compliant balloon
Active Comparator group
Description:
15 patients, before BVS implantation is coronary artery stenosis dilated with this type of balloon
Treatment:
Device: Predilatation with non-compliant balloon
Scoring balloon
Experimental group
Description:
15 patients, before BVS implantation is coronary artery stenosis dilated with this type of balloon
Treatment:
Device: Predilatation with scoring balloon (Scoroflex)
Cutting balloon
Experimental group
Description:
15 patients, before BVS implantation is coronary artery stenosis dilated with this type of balloon
Treatment:
Device: Predilatation with cutting balloon (Flextome)

Trial contacts and locations

0

Loading...

Central trial contact

Petra Jiroušková, Mgr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems